Company Monitoring Page for Mallinckrodt

latest headlines for company on cafepharma

Rejected: After paying $80M to acquire it, Mallinckrodt’s jaundice drug snubbed by FDA’s advisory committee
Endpoints
Thu, 05/3/18 - 11:09 pm
Tags:
Mallinckrodt, FDA, advisory panels, infantile jaundice, InfaCare, stannsoporfin
Mallinckrodt used 'dirty data' to snow payers on Acthar, whistleblower suit says
Fierce Pharma
Fri, 04/13/18 - 01:14 pm
Tags:
Mallinckrodt, whistleblower lawsuits, H.P. Acthar Gel, fraud
Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis
Fierce Pharma
Thu, 03/1/18 - 11:51 pm
Tags:
Mallinckrodt, oxymorphone, opioid crisis
Mallinckrodt builds pipeline through $1.2B Sucampo deal
Biopharma Dive
Thu, 12/28/17 - 09:20 am
Tags:
Mallinckrodt, Sucampo, M&A
Mallinckrodt continues pipeline revamp with Ocera buy
BioPharma Dive
Sat, 11/4/17 - 08:50 am
Tags:
Mallinckrodt, Ocera Therapeutics, M&A
Mallinckrodt bags another microcap biotech, picking up Ocera’s failed drug in $117M buyout
Endpoints
Thu, 11/2/17 - 09:17 am
Tags:
Mallinckrodt, Ocera Therapeutics, M&A
Mallinckrodt stifled Acthar competition, payer lawsuit claims, clearing path for 85,000% rise in prices
Fierce Pharma
Tue, 10/31/17 - 09:13 pm
Tags:
Mallinckrodt, Acthar, payers, Questcor, drug pricing
Mallinckrodt tumbles after judge invalidates Inomax patents
BioPharma Dive
Wed, 09/6/17 - 08:34 pm
Tags:
Mallinckrodt, Inomax, patents, Praxair
Mallinckrodt beats Q2 earnings, misses on revenue
Drug Delivery Business News
Tue, 08/8/17 - 11:21 pm
Tags:
Mallinckrodt, earnings
Mallinckrodt bags late-stage infantile jaundice drug in $425M InfaCare buyout deal
Endpoints
Mon, 08/7/17 - 11:25 am
Tags:
Mallinckrodt, infantile jaundice, InfaCare, M&A, Stanate
In a critical year for drugmakers, campaign donations, PAC activity are on the rise
Stat
Mon, 07/24/17 - 11:02 am
Tags:
PACs, campaign donations, Mallinckrodt, lobbying
Mallinckrodt Pharmaceuticals is facing scrutiny over the price of its blockbuster drug Acthar
Business Insider
Tue, 06/20/17 - 09:27 am
Tags:
drug pricing, Mallinckrodt, Acthar, PBMs, Express Scripts
3 Biotech Stocks That Could Become M&A Targets
Motley Fool
Sat, 06/17/17 - 03:05 pm
Tags:
biotech, M&A, Mallinckrodt, Tesaro, Incyte
Is Mallinckrodt in Talks to Be Sold?
Motley Fool
Tue, 06/13/17 - 10:14 pm
Tags:
Mallinckrodt, M&A
Instant Analysis: Mallinckrodt Considering Sale of Generics Unit
Motley Fool
Thu, 06/1/17 - 08:48 am
Tags:
Mallinckrodt, generics, M&A
Mallinckrodt exits PhRMA before new rules take hold
BioPharma Dive
Thu, 04/6/17 - 11:56 pm
Tags:
Mallinckrodt, PhRMA, R&D
Mallinckrodt to settle oxycodone diversion case for $35M with Justice Department
Fierce Pharma
Tue, 04/4/17 - 12:24 am
Tags:
Mallinckrodt, DOJ, oxycodone, DEA
Covidien spinout Mallinckrodt closes $690m sale of nuclear imaging biz
Mass Device
Mon, 01/30/17 - 11:53 am
Tags:
Covidien, Mallinckrodt, M&A, nuclear imaging, devices
Martin Shkreli: Mallinckrodt Will Be Punished
Benzinga
Thu, 01/19/17 - 08:35 am
Tags:
Martin Shkreli, Mallinckrodt, Questcor, Daraprim
The Most Expensive Drugs of 2016
Motley Fool
Mon, 12/19/16 - 11:32 am
Tags:
drug pricing, Gilead Sciences, Harvoni, Sovaldi, H.P. Acthar, Mallinckrodt, Shire, Cinryze, Daklinza, Bristol-Myers Squibb

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.